Balyasny Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-18,200
| Closed | -$54K | – | 2128 |
|
|
2018
Q1 | $54K | Buy |
18,200
+5,300
| +41% | +$15.7K | ﹤0.01% | 1670 |
|
|
2017
Q4 | $35K | Buy |
+12,900
| New | +$35K | ﹤0.01% | 1775 |
|
|
2017
Q2 | – | Sell |
-100,017
| Closed | -$227K | – | 1695 |
|
|
2017
Q1 | $227K | Buy |
100,017
+56,717
| +131% | +$129K | ﹤0.01% | 1286 |
|
|
2016
Q4 | $92K | Buy |
43,300
+11,968
| +38% | +$25.4K | ﹤0.01% | 1122 |
|
|
2016
Q3 | $105K | Sell |
31,332
-14,100
| -31% | -$47.3K | ﹤0.01% | 859 |
|
|
2016
Q2 | $143K | Sell |
45,432
-17,680
| -28% | -$55.6K | ﹤0.01% | 901 |
|
|
2016
Q1 | $210K | Buy |
63,112
+29,590
| +88% | +$98.5K | ﹤0.01% | 912 |
|
|
2015
Q4 | $119K | Buy |
+33,522
| New | +$119K | ﹤0.01% | 1018 |
|